[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Universitat Politècnica de Catalunya\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":103},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,50,80],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":4},"100636304","3d-movie-viewing-vs-occlusion-for-treating-amblyopia-in-children-100636304",false,"NCT07563946","3D Movie Viewing vs Occlusion for Treating Amblyopia in Children","Efficacy of 3D Movie Viewing Versus Occlusion on Stereopsis and Visual Function in Children With Amblyopia: A Randomized Controlled Trial","VISTA3D","Inclusion Criteria:\n\nChildren aged 4 to 14 years Diagnosis of unilateral amblyopia (anisometropic, strabismic, or mixed) Interocular visual acuity difference ≥ 0.2 logMAR (equivalent to ≥ 2 Snellen lines) Ability to understand and follow age-appropriate instructions Written informed consent from parents or legal guardians Child assent obtained when applicable\n\nExclusion Criteria:\n\nPrevious treatment for amblyopia Ocular surgery within the last 6 months Strabismus with deviation greater than 10 prism diopters Presence of other ocular pathologies affecting vision (e.g., cataract, nystagmus, ptosis, corneal opacity, retinal disease, optic neuropathy) Neurological or cognitive impairment preventing compliance with study procedures Prior intensive exposure to 3D movies or virtual reality\u002F3D video games that could act as a confounding factor Refusal of the child or family to participate","ALL","4 Years","14 Years",{"count":21,"type":22},56,"ESTIMATED","INTERVENTIONAL",[25],"NA","Amblyopia is a common childhood visual disorder that affects vision in one eye and can also impair depth perception (stereopsis). Standard treatment typically involves occlusion therapy (patching the stronger eye), which improves visual acuity but often does not fully restore binocular vision.\n\nThis study aims to evaluate whether watching 3D movies, combined with occlusion therapy, improves visual outcomes more than occlusion therapy alone in children with amblyopia. The immersive nature of 3D content may stimulate binocular vision and enhance treatment effectiveness.\n\nIn this randomized controlled trial, children aged 4 to 14 years with amblyopia will be assigned to one of two groups: one group will receive standard occlusion therapy, while the other will receive occlusion combined with weekly 3D movie sessions. After an initial phase, all participants will have access to 3D viewing sessions.\n\nThe study will assess improvements in depth perception, visual acuity, and eye alignment over time. The goal is to determine whether this combined approach provides additional benefits and could be used as a complementary therapy for amblyopia.",[28,29],"Anisometropic Amblyopia","Strabismic Amblyopia",[31,32,33,34,35,36,37],"Amblyopia","Stereopsis","3D Movie Viewing","Occlusion Therapy","Strabismus","Anisometropia","Binocular Treatment","NOT_YET_RECRUITING","2026-04-26",{"date":41,"type":42},"2026-05-04","ACTUAL",{"date":44,"type":22},"2026-05-01",{"date":46,"type":22},"2027-06-01",{"name":48,"class":49},"Universitat Politècnica de Catalunya","OTHER",{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":11,"sex":17,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":4,"studyType":23,"phases":62,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":75,"startDateStruct":76,"completionDateStruct":77,"leadSponsor":79,"locationsCount":4},"100636305","visual-therapy-for-intermittent-strabismus-100636305","NCT07563959","Visual Therapy for Intermittent Strabismus","Efficacy of Visual Therapy in Intermittent Non-Pathological Horizontal Strabismus: A Randomized Controlled Trial","ViT(I)S","Inclusion Criteria:\n\nIndividuals aged 8 to 50 years Diagnosis of intermittent horizontal strabismus (exotropia or esotropia) Absence of associated ocular, systemic, or neurological pathology Ability to understand and follow study instructions Willingness and motivation to complete 12 sessions of visual therapy (for the experimental group) Written informed consent (and assent for minors when applicable)\n\nExclusion Criteria:\n\nPrevious visual therapy treatment Inability to attend in-office visual therapy sessions Presence of ocular, systemic, or neurological disease affecting vision Constant strabismus Cognitive or intellectual impairment limiting the ability to perform the exercises","8 Years","50 Years",{"count":61,"type":22},30,[25],"Intermittent strabismus is a condition in which the eyes occasionally become misaligned, affecting binocular vision, depth perception, and quality of life. Standard treatment often involves surgery of the eye muscles, although its effectiveness and timing remain debated.\n\nVisual therapy is a non-invasive alternative that uses structured exercises to improve eye coordination and binocular vision. However, there is limited high-quality evidence supporting its effectiveness in intermittent strabismus.\n\nThis randomized controlled trial aims to evaluate whether a 12-session visual therapy program improves eye alignment, binocular vision, control of strabismus, and quality of life in individuals aged 8 to 50 years with intermittent horizontal strabismus.\n\nParticipants will be assigned to either a visual therapy group or a control group without treatment. Visual therapy will include weekly in-office sessions combined with short daily home exercises.\n\nThe study will assess changes before and after the intervention to determine whether visual therapy is an effective, non-invasive treatment option that could reduce the need for surgery.",[65,66,67],"Intermittent Strabismus","Exotropia Intermittent","Esotropia Intermittent",[65,69,70,71,72,73,74],"Visual Therapy","Binocular Vision","Exotropia","Esotropia","Pediatric and Adult Strabismus","Quality of Life",{"date":41,"type":42},{"date":44,"type":22},{"date":78,"type":22},"2028-07-01",{"name":48,"class":49},{"id":81,"slug":82,"hasResults":11,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":86,"eligibilityCriteria":87,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":88,"targetDuration":4,"studyType":23,"phases":90,"briefSummary":91,"conditions":92,"keywords":93,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":4},"100616133","vision-3d-visual-skills-improvement-with-on-screen-3d-movies-100616133","NCT07301645","VISION-3D: Visual Skills Improvement With On-screen 3D Movies.","Efficacy of 3D Versus 2D Movie Viewing on Stereopsis and Visual Function in Children With Residual Ambliopia. A Randomized Controlled Trial.","VISION3D","Inclusion Criteria:\n\n* Children aged 4 to 12 years.\n* Previous diagnosis of unilateral amblyopia (anisometropic, strabismic, or mixed).\n* History of conventional treatment (optical correction, occlusion and\u002For penalization) with stable visual acuity for at least 6 months.\n* Interocular visual acuity difference ≥ 0.2 logMAR (≈ ≥2 Snellen lines).\n* Ability to understand and follow age-appropriate basic instructions.\n* Parent\u002Fguardian consent (and child assent when applicable)\n\nExclusion Criteria:\n\n* Ocular surgery within the last 6 months.\n* Manifest strabismus \\>15 prism diopters.\n* Concomitant ocular pathology that may affect vision (e.g., cataract, nystagmus, ptosis, corneal opacity, retinal disease, optic neuropathy).\n* Cognitive or neurological deficits preventing compliance with the protocol.\n* Prior intensive exposure to 3D cinema or VR\u002F3D videogames that could act as a confounder.\n* Family or child refusal to participate",{"count":89,"type":22},40,[25],"This clinical study investigates whether watching 3D films can help improve the vision of children with residual amblyopia (lazy eye), that is, those children who, despite having undergone usual treatments such as glasses or patching, still maintain some visual deficit. The main objective is to verify whether viewing in 3D is better than viewing in 2D in improving depth vision (stereopsis), visual acuity and ocular alignment. The hypothesis is that 3D films, by providing richer binocular stimuli, will produce greater improvements than the same 2D films.\n\nChildren between 4 and 14 years of age with residual, stable and previously treated unilateral amblyopia will be included. Participants will be recruited from the pediatric ophthalmology\u002Foptometry clinics of the Mútua University Hospital\n\nThe study will be conducted in two locations: the visual examinations will be performed at the Mútua University Hospital in Terrassa, and the film sessions at the Faculty of Optics and Optometry of Terrassa (FOOT, UPC), in rooms prepared with a projector and 3D glasses.\n\nThe design is randomized and controlled. In a first phase, the children will be randomly divided into two groups: one group will watch 3 films in 3D and the other will watch the same films in 2D. Then, in a second phase, all participants will watch 3 additional sessions in 3D. Four evaluation visits will be made: before starting, after phase 1, after phase 2 and a follow-up two months later. These visits will measure stereopsis, visual acuity, and ocular deviation with standard optometric tests.\n\nWatching 3D movies is a safe and non-invasive activity; therefore, no significant risks are expected beyond some possible mild and transient discomfort such as eye strain or headache, which will be recorded if it occurs. Potential benefits include improved depth perception and other visual functions, and the results could open the door to new, fun and motivating therapeutic options for other children with amblyopia in the future.",[31,35],[31,35,94],"Cinema 3D","2025-12-10",{"date":97,"type":42},"2025-12-24",{"date":99,"type":22},"2026-01-15",{"date":101,"type":22},"2026-07",{"name":48,"class":49},""]